Komori
CellSource (4880) · TargetRestated

Addressing Social Issues and Creating New Standards in Healthcare

First written in FY2020. 2 of 4 entries say "Restated". Latest entry: FY2024-Q1.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020 – FY2021ReframedFY20222021: 120212022: 120222023: 120232024: 12024
Same theme, other companies
Contributing to Healthcare and Public Health through Innovative Pharmaceuticals and ServicesA theme 13 companies write about · 0 as a headwind · 13 as a tailwind

The whole theme swung hardest in 2025: 1 of 7 companies on the "Worse" side.

9 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q1RestatedAnnual report

    「Our company states “Change Our Future 未来を変える” as its purpose and “Freedom of Life with Medical Revolution すべての人生に自由を 医療に革命を” as its mission.」

    The purpose and mission reorganized in FY2022 continue to be stated.
  2. FY2022ReframedAnnual report

    「<Purpose: Our reason for existing in society> ● Change Our Future — Change the future <Mission: Our social mission> ● Freedom of Life with Medical Revolution — Freedom for every life, revolution in medicine」

    The previous mission and vision of solving social issues and creating new medical norms were reorganized into a framework encompassing the purpose, mission and values.
  3. FY2021RestatedAnnual report

    「<Mission: Our intended contribution to society> ● Solving the challenges of an aging population ● Solving the challenges of a declining birth rate ● Solving the problem of fiscal deficits (reducing public healthcare costs) <Vision: What our company should be> ● A company that addresses social issues thoroughly ● A company that creates new medical norms ● A company that takes on challenges proactively without fearing change」

    The company continues to state the resolution of social issues and the creation of new medical norms as its mission and vision.
  4. FY2020First statedAnnual report

    「<Mission: Our intended contribution to society> ● Solving the challenges of an aging population ● Solving the challenges of a declining birth rate ● Solving the problem of fiscal deficits (reducing public healthcare costs) <Vision: What our company should be> ● A company that addresses social issues thoroughly ● A company that creates new medical norms ● A company that takes on challenges proactively without fearing change」

    The company’s mission and vision explicitly identified the resolution of social issues associated with an aging population, a declining birth rate and fiscal deficits, as well as the creation of new medical norms.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Addressing Social Issues and Creating New Standards in Healthcare | CellSource Co.,Ltd. (4880) | Komori